Debido a que la coccidioidomicosis por lo general no produce sÃntomas o en la mayorÃa de las infecciones sintomáticas generalmente se resuelve con rapidez, por sà sola, sin producir sÃntomas significativos, generalmente no hay necesidad de evitar la infección. Las personas inmunocomprometidas, como los pacientes de SIDA y aquellos que consumen medicamentos inmunosupresores, pueden evitar viajar a regiones donde se encuentra este hongo, si desean minimizar el riesgo de desarrollar este trastorno crónico poco común.
Chiller TM. Coccidioidomycosis. Infect Dis Clin North Am . 2003; 17(1): 41-57, viii.
Murray J, Nadel J. Textbook of Respiratory Medicine . 3rd ed. Philadelphia, Pa: WB Saunders; 2000.
Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases . 5th ed. London, UK: Churchill Livingstone; 2000:2746-2755.
Galgiani JN, Ampel N, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis . 2005;41:1217-23.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |